Kaftrio may relieve sinonasal symptoms in CF patients: Study
Kaftrio, a combination of elexacaftor, tezacaftor, and ivacaftor marketed as Trikafta in the U.S., may relieve much of the discomfort...
Cystic fibrosis patients pitch for life-saving drugs that are currently unavailable in India
Cystic fibrosis is life-threatening as it damages both the lungs and the digestive system, with those undiagnosed often dying in infancy....
MAMI- Quality Improvement at Marmara CF Center in Istanbul
In December 2022, MECFA wrapped up a 2 year quality improvement program aimed at increasing patient health outcomes in Turkey. The MaMi...
Prevalence and Characteristics of Cystic Fibrosis in Omani Children:
Cystic fibrosis (CF) is a rare autosomal recessive disorder caused by mutations of the cystic fibrosis transmembrane conductance...
Tavanta Therapeutics to Present Preclinical Data for TAVT-135 at the North American Cystic Fibrosis
~ Tavanta is progressing TAVT-135, a novel pan-genotypic chloride ion transporter, in cystic fibrosis ~ KING OF PRUSSIA, Pa., Oct. 28,...
In Cystic Fibrosis, Early Childhood Weight-for-Age Affects Later Lung Function
In cystic fibrosis, weight at 1 year of age and weight-for-age trajectories across early childhood are associated with later pulmonary...
OSU RESEARCHERS DEVELOP IMPROVED CYSTIC FIBROSIS TREATMENT
Researchers at Oregon State University and Oregon Health & Science University have taken a key step toward improving and lengthening the...
Role of Inhalational Aztreonam Lysine in Lower Airway Infections in Cystic Fibrosis: An Updated Lite
Published: October 29, 2022 (see history) DOI: 10.7759/cureus.30833 Cite this article as: Zeb M, Poudel S, Gutlapalli S, et al. (October...
Inhaled hypertonic saline improves structural airway changes in children with cystic fibrosis
Inhaled hypertonic saline treatment for 48 weeks led to positive effects on structural lung changes in young children with cystic...
Hormone Infusion Improves Pancreatic Insulin Production in Cystic Fibrosis Patients with or at Risk
Medication therapy based on the hormone glucagon-like peptide-1(GLP-1) may help regulate natural insulin production in cystic fibrosis,...
